loadpatents
Patent applications and USPTO patent grants for LOCHMANN; Berit.The latest application filed is for "fusion proteins comprising a binding protein and an interleukin-15 polypeptide having a reduced affinity for il15ra and therapeutic uses thereof".
Patent | Date |
---|---|
FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15 POLYPEPTIDE HAVING A REDUCED AFFINITY FOR IL15Ra AND THERAPEUTIC USES THEREOF App 20210163564 - GUNDRAM; Jung ;   et al. | 2021-06-03 |
Fusion proteins comprising a binding protein and an interleukin-15 polypeptide having a reduced affinity for IL15Ra and therapeutic uses thereof Grant 10,906,952 - Gundram , et al. February 2, 2 | 2021-02-02 |
Recombinant Antibody Molecule And Its Use For Target Cell Restricted T Cell Activation App 20180208657 - JUNG; Gundram ;   et al. | 2018-07-26 |
FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15 POLYPEPTIDE HAVING A REDUCED AFFINITY FOR IL15Ra AND THERAPEUTIC USES THEREOF App 20180044391 - GUNDRAM; Jung ;   et al. | 2018-02-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.